Pharmacological management of obesity an endocrine society clinical practice guideline

Authors

  • Caroline M. Apovian Boston University School of Medicine and Boston Medical Center, Boston, Massachusetts, USA, United States
  • Louis J. Aronne Weill-Cornell Medical College, New York, New York, USA, United States
  • Daniel H. Bessesen Denver Health Medical Center, Denver, Colorado, USA, United States
  • Marie E. McDonnell Brigham and Women’s Hospital, Boston, Massachusetts, USA, United States
  • M. Hassan Murad Mayo Clinic, Division of Preventative Medicine, Rochester, Minnesota, USA, United States
  • Uberto Pagotto Alma Mater University of Bologna, Bologna, Italy, Italy
  • Donna H. Ryan Pennington Biomedical Research Center, Baton Rouge, Louisiana, USA, United States
  • Christopher D. Still Geisinger Health Care System, Danville, Pennsylvania, USA, United States

DOI:

https://doi.org/10.18370/2309-4117.2015.23.59-63

Keywords:

overweight, obesity, obesity pharmacotherapy, clinical management, Endocrine Society

Abstract

Objective: To formulate clinical practice guidelines for the pharmacological management of obesity.

Participants: An Endocrine Society-appointed Task Force of experts. This guideline was co-sponsored by the European Society of Endocrinology and The Obesity Society.

Evidence: This evidence-based guideline was developed using the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE ) system to describe the strength of

recommendations and the quality of evidence.

Conclusions: Weight loss is a pathway to health improvement for patients with obesity-associated risk factors and comorbidities. Medications approved for chronic weight management can be useful adjuncts to lifestyle change for patients who have been unsuccessful with diet and exercise alone. Many medications commonly prescribed for diabetes, depression, and other chronic diseases have weight effects, either to promote weight gain or produce weight loss. Knowledgeable prescribing of medications, choosing whenever possible those with favorable weight profiles, can aid in the prevention and management of obesity and thus improve health.

Author Biographies

Caroline M. Apovian, Boston University School of Medicine and Boston Medical Center, Boston, Massachusetts, USA

Школа медицины Бостонского университета и Бостонский медицинский центр

M. Hassan Murad, Mayo Clinic, Division of Preventative Medicine, Rochester, Minnesota, USA

Отдел профилактической медицины 

Downloads

Published

2015-06-24

How to Cite

Apovian, C. M., Aronne, L. J., Bessesen, D. H., McDonnell, M. E., Murad, M. H., Pagotto, U., Ryan, D. H., & Still, C. D. (2015). Pharmacological management of obesity an endocrine society clinical practice guideline. REPRODUCTIVE ENDOCRINOLOGY, (23), 59–63. https://doi.org/10.18370/2309-4117.2015.23.59-63

Issue

No. 23 (2015)

Section

Interdisciplinary problems

License

Copyright (c) 2015 Caroline M. Apovian, Louis J. Aronne, Daniel H. Bessesen, Marie E. McDonnell, M. Hassan Murad, Uberto Pagotto, Donna H. Ryan, Christopher D. Still

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with this journal agree to the following terms:

    1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

    1. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.